Catheter Precision Divests Non-Core Assets As It Shifts Focus
Catheter Precision (NYSE: VTAK) has announced a strategic divestiture of its non-core assets, leading to a decline in share prices. This strategic move may streamline operations, focusing resources on its core competencies and potentially improving long-term performance.
View signal analysis